Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14837310 | 1.00 | ZDHHC20 (0.40) | ZDHHC20ZDHHC2EPHX2GPR84FFAR1 | |
| SCHEMBL991670 | 0.98 | ZDHHC20 (0.38) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL991089 | 0.92 | ZDHHC20 (0.35) | ZDHHC20ZDHHC2ALDH1A1TSHR | |
| SCHEMBL2455781 | 0.92 | ZDHHC20 (0.44) | ZDHHC20ZDHHC2EPHX2LMNAALDH1A1 | |
| SCHEMBL16776749 | 0.92 | ZDHHC20 (0.44) | ZDHHC20ZDHHC2EPHX2LMNAALDH1A1 | |
| SCHEMBL16776767 | 0.89 | ZDHHC20 (0.42) | ZDHHC20ZDHHC2EPHX2LMNAALDH1A1 | |
| SCHEMBL14341773 | 0.85 | ZDHHC20 (0.38) | ZDHHC20ZDHHC2EPHX2LMNAALDH1A1 | |
| SCHEMBL4083031 | 0.84 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2EPHX2MEN1KMT2A | |
| SCHEMBL4423048 | 0.84 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2EPHX2MEN1KMT2A | |
| SCHEMBL2874278 | 0.84 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2EPHX2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10428200-B2 | Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups | BAXTER INTERNATIONAL INC. (US) | 2019-10-01 | — | — | US | disclosed |
| US-9895468-B2 | Immobilization of an active agent on a substrate | BAXTER INTERNATIONAL INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-20170218174-A1 | IMMOBILIZATION OF AN ACTIVE AGENT ON A SUBSTRATE USING COMPOUNDS INCLUDING TRIHYDROXYPHENYL GROUPS | VANTIVE US HEALTHCARE LLC | 2017-08-03 | — | — | US | disclosed |
| US-20170173226-A1 | Immobilization of an Active Agent on a Substrate | VANTIVE US HEALTHCARE LLC | 2017-06-22 | — | — | US | disclosed |
| US-9655917-B2 | Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups | BAXTER INTERNATIONAL INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-9642949-B2 | Immobilization of an active agent on a substrate | BAXTER INTERNATIONAL INC. (US) | 2017-05-09 | — | — | US | disclosed |
| EP-2968676-B1 | IMMOBILIZATION OF ACTIVE AGENT ON A SUBSTRATE | BAXTER INT (US) | 2017-05-03 | — | — | EP | disclosed |
| WO-2017066668-A1 | DRUG-LINKER CONJUGATE PHARMACEUTICAL COMPOSITIONS | BAYLOR UNIVERSITY (US) | 2017-04-20 | — | — | WO | disclosed |
| EP-3003413-A1 | IMMOBILIZATION OF AN ACTIVE AGENT ON A SUBSTRATE USING COMPOUNDS INCLUDING TRIHYDROXYPHENYL GROUPS | Baxter International Inc (US) | 2016-04-13 | — | — | EP | disclosed |
| CN-105377315-A | IMMOBILIZATION OF AN ACTIVE AGENT ON A SUBSTRATE USING COMPOUNDS INCLUDING TRIHYDROXYPHENYL GROUPS | BAXTER INT | 2016-03-02 | — | — | CN | disclosed |
| CN-102325797-A | Binder compositions comprising boric acid or boric acid salt | BASF SE | 2012-01-18 | — | — | CN | disclosed |
| US-20110257302-A1 | BINDER COMPOSITIONS COMPRISING BORIC ACID OR BORIC ACID SALT | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| CN-101228197-B | Amphoteric copolymers, their preparation and use | BASF AG | 2011-10-19 | — | — | CN | disclosed |
| CN-102037034-A | Polymer dispersions containing phosphorous polymers and emulsifiers | BASF SE | 2011-04-27 | — | — | CN | disclosed |
| WO-2011009874-A1 | AQUEOUS POLYMER DISPERSION AS A BINDING AGENT FOR PLASTERS AND COATING MATERIALS HAVING IMPROVED FIRE BEHAVIOR | BASF SE (DE) | 2011-01-27 | — | — | WO | disclosed |
| EP-2257579-A1 | POLYMER DISPERSIONS CONTAINING PHOSPHOROUS POLYMERS AND EMULSIFIERS | BASF SE (DE) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009115607-A1 | POLYMER DISPERSIONS CONTAINING PHOSPHOROUS POLYMERS AND EMULSIFIERS | BASF SE (DE) | 2009-09-24 | — | — | WO | disclosed |
| CN-101228197-A | Amphoteric copolymers, their preparation and use | BASF AG (DE) | 2008-07-23 | — | — | CN | disclosed |
| US-4243793-A | Prepolymers for photocurable compositions | PHILLIPS PETROLEUM COMPANY (US) | 1981-01-06 | — | — | US | disclosed |
| US-4119510-A | Photocurable diisocyanate compositions | PHILLIPS PETROLEUM COMPANY (US) | 1978-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428200-B2 | Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups | HAAO, APEH, PAH | ZDHHC20 1351/4885ZDHHC2 1919/4885EPHX2 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.